Pressure groups on Tuesday demanded that the WTO simplify the rules under which governments can import and producers export generic copies of drugs under patent, to tackle fears of a flu pandemic.
The groups, including Medecins Sans Frontieres (MSF), argue that easing the rules would encourage more producers to manufacture generic drugs under so-called compulsory licensing. Urgently needed drugs would become more widely available should the bird-flu virus change so that it can pass easily between humans.
The campaigners cite Tamiflu, which is produced by Switzerland's Roche Holding AG and is considered the only drug likely to be effective in an outbreak of the bird flu disease in humans. Governments have been scrambling to stockpile the drug in case of a pandemic.
"Tamiflu illustrates the danger of patent monopolies -- you have a shortage of a drug and don't have an easy remedy for a disease. This is exactly the situation when countries would have to use compulsory licenses for import and export," said Ellen 't Hoen, who directs the campaign for access to essential medicines at MSF, also known as Doctors Without Borders.
She said WTO rules were "not sufficient and robust enough to deal with public health crises."
Under WTO rules, countries can issue compulsory licenses to disregard patent rights but only after negotiating with the patent owners and paying them adequate compensation. If they declare a public health emergency, governments can skip the negotiating.
Initially the production of such generic drugs was strictly limited to domestic use. But in a decision in August 2003, the WTO for the first time allowed generic drugs under compulsory licenses to be exported, albeit under very strict conditions.
Although the decision was a response to poor countries' growing need for cheap generic drugs to tackle epidemics such as HIV/AIDS, critics now say that the complicated procedure to export such drugs has put off generic manufacturers.
"The rich countries congratulate themselves ... but in reality it does not bear fruit. In reality it removes the economic incentive for generic production," 't Hoen said.
Another issue is that many rich countries, including the US and the EU, opted out of the 2003 decision, meaning they would be unable to import generic drugs made under compulsory license even if they wanted to build up stocks against a disease outbreak, such as a flu pandemic.
Consumers International demands that countries that opted out be allowed to opt back in.
India has already said that it would consider using compulsory licensing to allow its drugmakers to copy Tamiflu.
Indian drugmaker Cipla Ltd -- which says it has developed a generic version of Tamiflu -- has applied to Roche for permission to copy the flu drug, but has pushed the Indian government to invoke compulsory licensing anyway.
A Taiwanese official said the country had no plans to begin manufacture of the Tamiflu because it has not yet received permission from Roche, even though many Taiwanese scientists are reportedly already able to produce Tamiflu copies in the laboratory.
Roche says it is considering a number of requests to make licensed versions, but did not elaborate.
‘A DISASTER’: A successful Chinese attack on Taiwan would undermine the credibility of US security guarantees and could result in a global depression, three experts wrote A Chinese takeover of Taiwan would be a geopolitical catastrophe for the US and its allies, one that would overshadow almost all others over the next decade, US policy experts said. Andrew Erickson, a professor of strategy in the US Naval War College’s China Maritime Studies Institute; Gabriel Collins, a fellow at Rice University’s Baker Institute for Public Policy; and former US deputy national security adviser Matthew Pottinger issued the warning in an article published on Tuesday in Foreign Affairs. Bejing’s invasion or annexation of Taiwan “would be a disaster of utmost importance to the United States, and I am convinced that
Taiwanese businesspeople’s investments in China last year hit a record low of 11.4 percent of total foreign investment, the Mainland Affairs Council said yesterday. The number was a huge decline from 83.8 percent in 2010, mainly because Taiwanese businesspeople have been diversifying their investments globally over the past few years, with great success, the council said. From 1991 to last year, 45,523 Taiwanese investments in China totaling US$206.37 billion had been approved, accounting for 50.7 percent of overall foreign investment, data from the Ministry of Economic Affairs’ Investment Commission showed. The amount and proportion of Taiwanese investments in China has been declining, with
Taiwanese tourists on board a Kinmen cruise ship had a scare yesterday when it was intercepted by Chinese coast guards who forcefully boarded the vessel to inspect it. The Sunrise, a tourism ferry that operates between Kinmen and Xiamen, China, was sailing around the waters around the islets of Dadan (大膽) and Erdan (二膽) — both of which are part of Kinmen County — yesterday afternoon when it encountered personnel from China’s Fujian Coast Guard Bureau. China Coast Guard personnel forced their way on board and conducted an inspection for about 30 minutes before leaving, local media cited the tourists as saying. The
CHINA’S VERSION: The TAO threatened Taiwan and denied the existence of restricted waters around Kinmen County after two Chinese died fleeing the Taiwanese coast guard Taiwan would continue to enforce the law in restricted waters around Kinmen County, the Mainland Affairs Council (MAC) said yesterday. The council was responding after China’s Taiwan Affairs Office (TAO) spokeswoman Zhu Fenglian (朱鳳蓮) on Saturday rejected the existence of restricted waters around Kinmen County — a group of Taiwanese islands close to China’s coast — and said that Beijing reserves the right to take further measures after two Chinese died in the area. The two died on Wednesday after the speedboat they were in capsized while they were being pursued by Taiwanese Coast Guard Administration (CGA) officials. The speedboat had entered